The “Medical Bypass”: new drugs to strike obesity
Pharmaceutical Technology
NOVEMBER 30, 2022
In 1997, the World Health Organization (WHO) classified obesity as a chronic disease. The company’s weight loss drug Saxenda (liraglutide) won an approval for chronic weight management in December 2014, and Wegovy (semaglude) got the same tag in 2021. of adults were overweight, 42.4% were obese, and 9.2% had severe obesity.
264 
Let's personalize your content